Patents by Inventor Peter Licari

Peter Licari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ISOLATED PLANT PROTEIN
    Publication number: 20220264908
    Abstract: An isolated plant protein comprising both native and denatured proteins, food compositions containing such isolates, and methods for preparing isolated plant protein are disclosed. In some embodiments, the hardness and gel elasticity of the isolated plant protein can be controlled by controlling the amounts of native protein and denatured protein present in the plant protein isolate.
    Type: Application
    Filed: February 18, 2022
    Publication date: August 25, 2022
    Inventors: Meng LI, Michael JAMROS, Swetha MAHADEVAN, Viviane LANQUAR, Camilla HEROLD, Peter LICARI
  • Therapeutic formulations of desoxyepothilones
    Publication number: 20100137382
    Abstract: Formulations of desoxyepothilones are stable before and after dilution into aqueous media.
    Type: Application
    Filed: March 15, 2005
    Publication date: June 3, 2010
    Inventors: Peter Licari, Ziyang Zhong, Indu Isaacs, John Augustine
  • Method of producing a compound by fermentation
    Patent number: 7459294
    Abstract: During the production of a product compound by fermentation, the concentration of a precursor compound is maintained within a pre-selected concentration range by having an adsorbent resin in contact with the culture medium. The adsorbent resin reversibly adsorbs precursor compound and, as un-adsorbed precursor compound is converted to product compound, adsorbed precursor compound is released from the resin, thus maintaining the concentration of precursor compound within the pre-selected range.
    Type: Grant
    Filed: August 6, 2004
    Date of Patent: December 2, 2008
    Assignee: Kosan Biosciences Incorporated
    Inventors: Timothy A. Leaf, Ruchir P. Desai, Peter Licari, Elaine Jennifer Woo
  • 17-Allylamino-17-demethoxygeldanamycin polymorphs and formulations
    Publication number: 20070203110
    Abstract: Polymorphs and pharmaceutical formulations of 17-allylamino-17-demethoxygeldanamycin (17-AAG).
    Type: Application
    Filed: November 8, 2006
    Publication date: August 30, 2007
    Inventors: Peter Licari, Timothy Leaf, Ruchir Desai, Jorge Galazzo, Greg Buchanan, Stephen Watt, Alexander Eberlin, Robert Arslanian
  • Production of polyketides
    Publication number: 20070092954
    Abstract: Recombinant Myxococcus host cells can be used to produce polyketides, including epothilone and epothilone analogs that can be purified from the fermentation broth and crystallized.
    Type: Application
    Filed: August 8, 2005
    Publication date: April 26, 2007
    Inventors: Robert Arslanian, Gary Ashley, Scott Frykman, Bryan Julien, Leonard Katz, Chaitan Khosla, Janice Lau, Peter Licari, Rika Regentin, Daniel Santi, Li Tang
  • Therapeutic formulations of desoxyepothilones
    Publication number: 20050277682
    Abstract: Formulations of desoxyepothilones are stable before and after dilution into aqueous media.
    Type: Application
    Filed: March 15, 2005
    Publication date: December 15, 2005
    Inventors: Peter Licari, Ziyang Zhong, Indu Isaacs, John Augustine
  • Pharmaceutical solution formulations containing 17-AAG
    Publication number: 20050256097
    Abstract: A pharmaceutical solution formulation containing 17-AAG in an amount of up to 15 mg/mL dissolved in a vehicle comprising (i) a first component that is ethanol, in an amount of between about 40 and about 60 volume %; (ii) a second component that is a polyethoxylated castor oil, in an amount of between about 15 to about 50 volume %; and (iii) a third component that is selected from the group consisting of propylene glycol, PEG 300, PEG 400, glycerol, and combinations thereof, in an amount of between about 0 and about 35 volume %.
    Type: Application
    Filed: May 5, 2005
    Publication date: November 17, 2005
    Applicant: Kosan Biosciences, Inc.
    Inventors: Ziyang Zhong, Peter Licari
  • Method of producing a compound by fermentation
    Publication number: 20050130283
    Abstract: During the production of a product compound by fermentation, the concentration of a precursor compound is maintained within a pre-selected concentration range by having an adsorbent resin in contact with the culture medium. The adsorbent resin reversibly adsorbs precursor compound and, as un-adsorbed precursor compound is converted to product compound, adsorbed precursor compound is released from the resin, thus maintaining the concentration of precursor compound within the pre-selected range.
    Type: Application
    Filed: August 6, 2004
    Publication date: June 16, 2005
    Applicant: Kosan Biosciences, Inc.
    Inventors: Timothy Leaf, Ruchir Desai, Peter Licari, Elaine Woo
  • Fermentation and purification of migrastatin and analog
    Publication number: 20040209336
    Abstract: Migrastatin and a migrastatin analog can be produced by fermentation of Streptomyces platensis NRRL 18993 and used in pharmaceutical formulations to treat cancer and/or inhibit metastasis of cancer cells.
    Type: Application
    Filed: May 3, 2004
    Publication date: October 21, 2004
    Inventors: Chaitan Khosla, Peter Licari, John Carney
  • Fermentation and purification of migrastatin and analog
    Patent number: 6750047
    Abstract: Migrastatin and a migrastatin analog can be produced by fermentation of Streptomyces platensis NRRL 18993 and used in pharmaceutical formulations to treat cancer and/or inhibit metastasis of cancer cells.
    Type: Grant
    Filed: August 17, 2001
    Date of Patent: June 15, 2004
    Assignee: Kosan Biosciences, Inc.
    Inventors: Chaitan Khosla, Peter Licari, John Carney
  • Fermentation and purification of mycolactones
    Patent number: 6562602
    Abstract: Fermentation based methods for producing mycolactones allows one to produce large quantities of mycolactones, which can be purified by extraction and chromatography to yield pure preparations of mycolactones A, B, C, and D.
    Type: Grant
    Filed: August 3, 2001
    Date of Patent: May 13, 2003
    Assignee: Kosan Biosciences, Inc.
    Inventors: Peter Licari, Robert Arslanian, Lawrence Cadapan, John Carney
  • Fermentation and purification of migrastatin and analog
    Publication number: 20020119937
    Abstract: Migrastatin and a migrastatin analog can be produced by fermentation of Streptomyces platensis NRRL 18993 and used in pharmaceutical formulations to treat cancer and/or inhibit metastasis of cancer cells.
    Type: Application
    Filed: August 17, 2001
    Publication date: August 29, 2002
    Inventors: Chaitan Khosla, Peter Licari, John Carney
  • Fermentation and purification of mycolactones
    Publication number: 20020086375
    Abstract: Fermentation based methods for producing mycolactones allows one to produce large quantities of mycolactones, which can be purified by extraction and chromatography to yield pure preparations of mycolactones A, B, C, and D.
    Type: Application
    Filed: August 3, 2001
    Publication date: July 4, 2002
    Inventors: Peter Licari, Robert Arslanian, Lawrence Cadapan, John Carney